Literature DB >> 14517745

Developmental hemostasis: pro- and anticoagulant systems during childhood.

Stefan Kuhle1, Christoph Male, Lesley Mitchell.   

Abstract

An understanding of developmental hemostasis is pivotal for optimal prevention, diagnosis, and treatment of hemostatic problems during childhood. The development of microassays in the early 1980s enabled researchers to delineate age-dependent features of the coagulation system and to establish reference ranges for healthy children of all age groups, from premature infants to adolescents. Based on the results from these studies, the hemostatic system in the young can be described as evolving, and yet functional, since healthy fetuses, infants, and children do not suffer hemorrhagic nor thromboembolic complications spontaneously or in the presence of minor challenges. Plasma concentrations of most pro- and anticoagulant proteins are decreased throughout childhood but provide an effective hemostatic balance on a lower level compared with adults. The current article describes the development of pro- and anticoagulant systems throughout childhood.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14517745     DOI: 10.1055/s-2003-42584

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  23 in total

1.  Protein S modulates the anticoagulant action of recombinant human activated protein C: a comparison between neonates and adults.

Authors:  Gerhard Cvirn; Martin Koestenberger; Bettina Leschnik; Christoph Male; Joerg Kutschera; Ulrika Ferstl; Wolfgang Muntean; Guenther Juergens; Siegfried Gallistl
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

2.  Fibrin Network Changes in Neonates after Cardiopulmonary Bypass.

Authors:  Ashley C Brown; Riley T Hannan; Lucas H Timmins; Janet D Fernandez; Thomas H Barker; Nina A Guzzetta
Journal:  Anesthesiology       Date:  2016-05       Impact factor: 7.892

Review 3.  Neonatal brain hemorrhage (NBH) of prematurity: translational mechanisms of the vascular-neural network.

Authors:  Tim Lekic; Damon Klebe; Roy Poblete; Paul R Krafft; William B Rolland; Jiping Tang; John H Zhang
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

4.  Anticoagulant action of melagatran: a comparison between neonates and adults using calibrated automated thrombography (CAT).

Authors:  Gerhard Cvirn; Christina Cimenti; Joerg Kutschera; Ulrika Ferstl; Thomas Wagner; Wolfgang Muntean; Gunther Jurgens; Siegfried Gallistl; Martin Koestenberger
Journal:  Eur J Pediatr       Date:  2006-09-19       Impact factor: 3.183

Review 5.  The host response to sepsis and developmental impact.

Authors:  James Wynn; Timothy T Cornell; Hector R Wong; Thomas P Shanley; Derek S Wheeler
Journal:  Pediatrics       Date:  2010-04-26       Impact factor: 7.124

6.  Successful mechanical thrombectomy in a 2-year-old male through a 4-French guide catheter.

Authors:  David A Stidd; Demetrius K Lopes
Journal:  Neurointervention       Date:  2014-09-03

7.  Population pharmacokinetics of epsilon-aminocaproic acid in infants undergoing craniofacial reconstruction surgery.

Authors:  P A Stricker; A F Zuppa; J E Fiadjoe; L G Maxwell; E M Sussman; E Y Pruitt; T K Goebel; M R Gastonguay; J A Taylor; S P Bartlett; M S Schreiner
Journal:  Br J Anaesth       Date:  2013-01-25       Impact factor: 9.166

Review 8.  Neonatal platelets: mediators of primary hemostasis in the developing hemostatic system.

Authors:  Kristina M Haley; Michael Recht; Owen J T McCarty
Journal:  Pediatr Res       Date:  2014-06-18       Impact factor: 3.756

9.  Pediatric Sepsis - Part I: "Children are not small adults!"

Authors:  Derek S Wheeler; Hector R Wong; Basilia Zingarelli
Journal:  Open Inflamm J       Date:  2011-10-07

10.  Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies.

Authors:  Jean-Louis Vincent; Simon Nadel; Demetrios J Kutsogiannis; R T Noel Gibney; S Betty Yan; Virginia L Wyss; Joan E Bailey; Carol L Mitchell; Samiha Sarwat; Stephen M Shinall; Jonathan M Janes
Journal:  Crit Care       Date:  2005-05-17       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.